These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22480965)

  • 1. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT
    Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and outcomes in patients with advanced melanoma in France.
    Bedane C; Leccia MT; Sassolas B; Bregman B; Lebbé C;
    Curr Med Res Opin; 2013 Oct; 29(10):1297-305. PubMed ID: 23808961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International practice patterns and resource utilization in the treatment of neuroendocrine tumors.
    Casciano R; Wang X; Stern L; Parikh R; Chulikavit M; Willet J; Liu Z; Strosberg J; Cadiot G; Riechelmann R
    Pancreas; 2013 Mar; 42(2):339-47. PubMed ID: 23357923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
    Reyes C; DaCosta Byfield S; Linke R; Satram-Hoang S; Teitelbaum AH
    Melanoma Res; 2013 Apr; 23(2):159-66. PubMed ID: 23370422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.
    Traverso CE; Walt JG; Kelly SP; Hommer AH; Bron AM; Denis P; Nordmann JP; Renard JP; Bayer A; Grehn F; Pfeiffer N; Cedrone C; Gandolfi S; Orzalesi N; Nucci C; Rossetti L; Azuara-Blanco A; Bagnis A; Hitchings R; Salmon JF; Bricola G; Buchholz PM; Kotak SV; Katz LM; Siegartel LR; Doyle JJ
    Br J Ophthalmol; 2005 Oct; 89(10):1245-9. PubMed ID: 16170109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Descriptive study of the costs of diagnosis and treatment of cutaneous melanoma].
    Almazán-Fernández FM; Serrano-Ortega S; Moreno-Villalonga JJ
    Actas Dermosifiliogr; 2009 Nov; 100(9):785-91. PubMed ID: 19889300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).
    Lebbe C; Lorigan P; Ascierto P; Testori A; Bédane C; Middleton M; van Baardewijk M; Konto C; Dueymes A; Maio M
    Eur J Cancer; 2012 Nov; 48(17):3205-14. PubMed ID: 22742880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
    Ezenduka C; Ichoku H; Ochonma O
    J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of socioeconomic factors on outcome and hospital costs associated with femoropopliteal revascularization.
    Durham CA; Mohr MC; Parker FM; Bogey WM; Powell CS; Stoner MC
    J Vasc Surg; 2010 Sep; 52(3):600-6; discussion 606-7. PubMed ID: 20598840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the use of health resources by Spanish and immigrant HIV-infected patients.
    Velasco M; Castilla V; Guijarro C; Moreno L; Barba R; Losa JE
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):458-62. PubMed ID: 22377495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.